Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paul Rubiro
Institution:
La Jolla Institute for Immunology
Observed institution:
La Jolla Institute for Immunology
ORCID:
0000-0002-6001-643X
Observed ORCID:
0000-0002-6001-643X
OpenAlex ID:
A5027685161
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
2020
·
Jose Mateus
, Alba Grifoni
, et al.
·
Science
·
1,154
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
2021
·
Alison Tarke
, John Sidney
, et al.
·
Cell Reports Medicine
·
720
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
2021
·
Alison Tarke
, John Sidney
, et al.
·
Cell Reports Medicine
·
552
Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans
2022
·
Alba Grifoni
, Yun Zhang
, et al.
·
Cell Host & Microbe
·
74
PDF
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
2023
·
Ricardo da Silva Antunes
, Daniela Weiskopf
, et al.
·
Current Protocols
·
46
PDF
Identification and Characterization of CD4 + T Cell Epitopes after Shingrix Vaccination
2020
·
Hannah Voic
, Rory D. de Vries
, et al.
·
Journal of Virology
·
30
PDF
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B
2022
·
Payel Roy
, John Sidney
, et al.
·
Circulation Research
·
27
Show more works
View as search
Works count:
7
Citation count:
2,603
H-index:
7
I10-index:
7
Year
Topic
Type